Condition: Cervical Cancer · Gastric/Gastroesophageal Junction Adenocarcinoma · Microsatellite Stable Colorectal Cancer · Sponsor: Bristol-Myers Squibb
The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab, docetaxel, or Pumitamig in participants with advanced solid tumors. This study is a first-in-human (FIH) study of BMS-986340 in participants with advanced solid tumors.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Community Cancer Institute | Clovis, California, United States | Recruiting |
| USC/Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian | Newport Beach, California, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| John Theurer Cancer Center | Hackensack, New Jersey, United States | Recruiting |
| Local Institution - 0006 | New York, New York, United States | Completed |
| Local Institution - 0002 | New York, New York, United States | Completed |
| Providence Cancer Center Oncology and Hematology Care- Eastside | Portland, Oregon, United States | Recruiting |
| Local Institution - 0063 | Nashville, Tennessee, United States | Not Yet Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
| Houston Methodist Hospital | Houston, Texas, United States | Recruiting |
| Blacktown Hospital | Blacktown, New South Wales, Australia | Recruiting |
+ 35 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04895709